Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Citi
McKesson
Cerilliant
Baxter
Chinese Patent Office
Healthtrust
Mallinckrodt
US Army
Argus Health

Generated: October 23, 2017

DrugPatentWatch Database Preview

CARDIOLITE Drug Profile

« Back to Dashboard

Which patents cover Cardiolite, and when can generic versions of Cardiolite launch?

Cardiolite is a drug marketed by Lantheus Medcl and is included in one NDA.

The generic ingredient in CARDIOLITE is technetium tc-99m sestamibi kit. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the technetium tc-99m sestamibi kit profile page.

Summary for Tradename: CARDIOLITE

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list9
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARDIOLITE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medcl
CARDIOLITE
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION019785-001Dec 21, 1990APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CARDIOLITE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medcl
CARDIOLITE
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
Lantheus Medcl
CARDIOLITE
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
Lantheus Medcl
CARDIOLITE
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
Lantheus Medcl
CARDIOLITE
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
Lantheus Medcl
CARDIOLITE
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Merck
US Army
Boehringer Ingelheim
Fish and Richardson
Johnson and Johnson
Julphar
Deloitte
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot